Star Scientific Says Shareholder Drug Suit Falls Short

Law360, Los Angeles (October 28, 2013, 9:43 PM EDT) -- Nutritional supplements manufacturer Star Scientific Inc. on Friday asked a Virginia federal court to throw out a suit claiming the company misled shareholders about the backgrounds of some of its scientists, saying the consolidated derivative action doesn’t adequately show bad intent.

Shareholders sued Star Scientific in May, claiming the company falsely linked Johns Hopkins University to one of its clinical tests and delayed releasing information about a federal investigation of the company, sending share share prices down 12 and 17 percent, respectively, when those bits of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.